AAAAAA
Results: 26-36/36
Authors:
KORNEK G
RADERER M
DEPISCH D
HAIDER K
FAZENY B
DITTRICH C
SCHEITHAUER W
Citation: G. Kornek et al., AMONAFIDE AS FIRST-LINE CHEMOTHERAPY FOR METASTATIC BREAST-CANCER, European journal of cancer, 30A(3), 1994, pp. 398-400
Authors:
DITTRICH C
ZIFKO U
FAZENY B
FIEGL M
GRISOLD W
HUBER H
Citation: C. Dittrich et al., VINORELBINE AFTER PACLITAXEL IN BREAST-CANCER - CROSS-RESISTANCE AND CUMULATIVE NEUROTOXICITY, Annals of oncology, 5(5), 1994, pp. 473-474
Authors:
DITTRICH C
LINN K
Citation: C. Dittrich et K. Linn, METAL-IONS FROM WASTE-WATERS BY SOLVENT-E XTRACTION - WASTE-WATER PROCESSING FREE ON HOUSE, Metall, 48(4), 1994, pp. 268-270
Authors:
FRIDRIK MA
GREIL R
HAUSMANINGER H
KRIEGER O
OPPITZ P
STOGER M
KLOCKER J
NEUBAUER M
DITTRICH C
HELM W
Citation: Ma. Fridrik et al., VALUE OF RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR (R-METHUG-CSF) IN THE TREATMENT OF AGGRESSIVE NON-HODGKINS-LYMPHOMAS (NHL)WITH AN INTENSIVE WEEKLY CHEMOTHERAPY SCHEDULE - AN AUSTRIAN RANDOMIZED MULTICENTER TRIAL, Blood, 84(10), 1994, pp. 10000023-10000023
Authors:
DITTRICH C
BAUR M
VAVRA N
HUDEC M
FAZENY B
BARRADA M
SALZER H
SEVELDA P
Citation: C. Dittrich et al., ETOPOSIDE AND CARBOPLATIN AS SALVAGE AND 1ST-LINE THERAPY IN OVARIAN-CANCER PATIENTS, Annals of oncology, 4(8), 1993, pp. 697-699
Authors:
KYRLE PA
BRENNER B
MANNHALTER C
SCHERRER R
HAUSER I
DITTRICH C
LECHNER K
Citation: Pa. Kyrle et al., IDENTICAL VON-WILLEBRAND-FACTOR (VWF) MULTIMER ABNORMALITIES IN IDIOPATHIC AND SECONDARY TUMOR-ASSOCIATED THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP), Thrombosis and haemostasis, 69(6), 1993, pp. 949-949
Authors:
GRUNT TW
OELLER H
SOMAY C
DITTRICH C
Citation: Tw. Grunt et al., DIFFERENT PROPENSITY FOR SPONTANEOUS DIFFERENTIATION OF CELL CLONES ISOLATED FROM THE HUMAN OVARIAN SURFACE EPITHELIAL-CELL LINE HOC-7, Differentiation, 53(1), 1993, pp. 45-50
Authors:
SEVELDA P
KURZ C
OBERMAIR A
VAVRA N
BREITENECKER G
CZERWENKA K
DITTRICH C
SALZER H
Citation: P. Sevelda et al., THE IMPORTANCE OF PLATINUM DOSE INTENSITY IN TREATMENT OF EPITHELIAL OVARIAN-CANCER, Wiener Klinische Wochenschrift, 105(24), 1993, pp. 732-736
Authors:
GRUNT TW
OELLER H
SOMAY C
DITTRICH E
FAZENY B
MANNHALTER C
DITTRICH C
Citation: Tw. Grunt et al., MODULATION OF THE IMMUNOPHENOTYPE OF OVARIAN-CANCER CELLS BY N,N-DIMETHYLFORMAMIDE AND TRANSFORMING GROWTH-FACTOR-BETA-1, Journal of cellular physiology, 156(2), 1993, pp. 358-366
Authors:
DITTRICH C
SEVELDA P
BAUR M
MARTH C
HUDEC M
VAVRA N
GRUNT T
FAZENY B
SALZER H
Citation: C. Dittrich et al., INVITRO AND INVIVO EVALUATION OF THE COMBINATION OF CISPLATIN AND ITSANALOG CARBOPLATIN FOR PLATINUM DOSE INTENSIFICATION IN OVARIAN-CARCINOMA, Cancer, 71(10), 1993, pp. 3082-3090
Authors:
HARANT H
KORSCHINECK I
KRUPITZA G
FAZENY B
DITTRICH C
GRUNT TW
Citation: H. Harant et al., RETINOIC ACID RECEPTORS IN RETINOID-RESPONSIVE OVARIAN-CANCER CELL-LINES DETECTED BY POLYMERASE CHAIN-REACTION FOLLOWING REVERSE TRANSCRIPTION, British Journal of Cancer, 68(3), 1993, pp. 530-536